A phenolic small molecule inhibitor of RNase L prevents cell death from ADAR1 deficiency
Salima Daou(Lunenfeld-Tanenbaum Research Institute), Frank Sicheri(University of Toronto), Nicole M. Duffy(Christiana Care Health System), Abiodun A. Ogunjimi(Mount Sinai Hospital), Manisha Talukdar(Mount Sinai Hospital), Susan R. Weiss(Philadelphia University), Christina Gaughan(Cleveland Clinic Lerner College of Medicine), Hao Huang(Peking University), Babal K. Jha(Cleveland Clinic), Daniel Y.L. Mao(Mount Sinai Hospital), Robert H. Silverman(Cleveland Clinic Lerner College of Medicine), Gerald Gish(Mount Sinai Hospital), Beihua Dong(Cleveland Clinic), Yize Li(Northeast Agricultural University), Nicolas Tavernier(Centre National de la Recherche Scientifique), Shuvojit Banerjee(Cleveland Clinic Lerner College of Medicine), Jinle Tang(Peking University)
Cited by 34
Related Papers
Crystal structure of the Src family tyrosine kinase Hck
|Nature|1997|1.2k
The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule
|Proceedings of the National Academy of Sciences|2012|594
The origins of SARS-CoV-2: A critical review
|Cell|2021|511
Crystal Structure of Hck in Complex with a Src Family–Selective Tyrosine Kinase Inhibitor
|Molecular Cell|1999|426